DNA & Genetics OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS PanelBy adminNovember 15, 20250 Today, OGT announced the launch of a new next-generation sequencing (NGS) panel for Measurable Residual Disease (MRD) – the SureSeq™…
DNA & Genetics Cellares and Technology Provider Team Plan to Expand Cell Q’s Capabilities for Commercial Scale Cell Therapy QCBy adminSeptember 19, 20250 Officials at Cellares say the Integrated Development and Manufacturing Organization (IDMO) entered multiple strategic technology partnerships to advance the Cell…
